Cargando…
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells
Triplebodies are antibody-derived recombinant proteins carrying 3 antigen-binding domains in a single polypeptide chain. Triplebody SPM-1 was designed for lysis of CD19-bearing malignant B-lymphoid cells through the engagement of CD16-expressing cytolytic effectors, including NK and γδ T cells. SPM-...
Autores principales: | Schiller, Christian B., Braciak, Todd A., Fenn, Nadja C., Seidel, Ursula J. E., Roskopf, Claudia C., Wildenhain, Sarah, Honegger, Annemarie, Schubert, Ingo A., Schele, Alexandra, Lämmermann, Kerstin, Fey, Georg H., Jacob, Uwe, Lang, Peter, Hopfner, Karl-Peter, Oduncu, Fuat S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347777/ https://www.ncbi.nlm.nih.gov/pubmed/27825135 http://dx.doi.org/10.18632/oncotarget.13110 |
Ejemplares similares
-
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
por: Braciak, Todd A., et al.
Publicado: (2018) -
P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
por: Fey, G, et al.
Publicado: (2014) -
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell
por: Roskopf, Claudia C., et al.
Publicado: (2014) -
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2
por: Braciak, Todd A, et al.
Publicado: (2013) -
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells
por: Roskopf, Claudia C., et al.
Publicado: (2016)